H-1337 1.0%

DRUG2 trials

Sponsors

D. Western Therapeutics Institute, Inc.

Conditions

Glaucoma Open-Angle PrimaryOcular Hypertension

Phase 1

Open-Label Study of Safety of H1337 in Healthy Volunteers

CompletedNCT06572397

D. Western Therapeutics Institute, Inc.Glaucoma Open-Angle Primary, Ocular Hypertension

Start: 2024-09-16End: 2024-10-14Updated: 2025-02-11

Phase 2

Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

CompletedNCT05913232

D. Western Therapeutics Institute, Inc.Glaucoma Open-Angle Primary, Ocular Hypertension

Start: 2023-08-28End: 2024-08-29Updated: 2025-08-27